Top compounds associated with response to LINC01420


Feature Type Standardized
Nominal ANOVA
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA Mdivi-1 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Curcumin CTRPv2 pan-cancer AAC -0.023 0.5
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC -0.024 0.5
mRNA JW-74 CTRPv2 pan-cancer AAC -0.03 0.5
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.035 0.5
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.047 0.5
Download CSV